Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Huetter-Kroenke, Marie-Luise; Benner, Axel; Doehner, Konstanze et al.
Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapyHAEMATOLOGICA. Bd. 101. H. 7. 2016 S. 839-845
Faller, Hermann; Koch, Uwe; Braehler, Elmar et al.
Satisfaction with information and unmet information needs in men and women with cancerJOURNAL OF CANCER SURVIVORSHIP. Bd. 10. H. 1. 2016 S. 62-70
Lutz, Manfred P.; Zalcberg, John R.; Glynne-Jones, Rob et al.
Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancerEUROPEAN JOURNAL OF CANCER. Bd. 63. 2016 S. 11-24
Frees, Sebastian; Beraldi, Eliana; Chi, Kim et al.
SECOND-GENERATION ANTISENSE OLIGONUCLEOTIDE-HSP27 A NEW INTRAVESICAL TREATMENT FOR BLADDER CANCER: PHASE 1CLINICAL TRIAL.JOURNAL OF UROLOGY. Bd. 195. H. 4. 2016 S. E142-E142
Gunst, Diana Christine Maria; Kaatsch, Peter; Goldbeck, Lutz
Seeing the good in the bad: which factors are associated with posttraumatic growth in long-term survivors of adolescent cancer?SUPPORTIVE CARE IN CANCER. Bd. 24. H. 11. 2016 S. 4607-4615
Herzer, Kerstin; Strassburg, Christian P.; Braun, Felix et al.
Selection and use of immunosuppressive therapies after liver transplantation: current German practiceCLINICAL TRANSPLANTATION. Bd. 30. H. 5. 2016 S. 487-501
Sagheb, Keyvan; Sagheb, Kawe; Rahimi-Nedjat, Roman et al.
Sentinel lymph node biopsy in T1/T2 squamous cell carcinomas of the tongue: A prospective studyONCOLOGY LETTERS. Bd. 11. H. 1. 2016 S. 600-604
Gross, Stefanie; Lennerz, Volker; Gallerani, Elisa et al.
Short Peptide Vaccine Induces CD4(+) T Helper Cells in Patients with Different Solid CancersCANCER IMMUNOLOGY RESEARCH. Bd. 4. H. 1. 2016 S. 18-25
Schwentner, L.; Harbeck, N.; Singer, S. et al.
Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized Adebar trialCANCER RESEARCH. Bd. 76. 2016
Schwentner, L.; Harbeck, N.; Singer, S. et al.
Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized Adebar trialCANCER RESEARCH. Bd. 76. 2016